Physician profile
Jared Ridenour
NPI 1619441177
$4,656.60
in general payments reported to CMS, 2019-2025
12 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.54 · 2022: $1,455 · 2023: $1,653 · 2024: $1,007 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924 · Travel and Lodging: $1,199 · Education: $32.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.80 |
| Travel and Lodging | $1,199.27 |
| Education | $32.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,946.07 | 2022-2024 | |
| Corelink, LLC | $1,044.90 | 2022 | |
| Cerapedics INC. | $655.16 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $321.43 | 2022-2024 | Unid_pass, Magnifuse Bone Graft, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Stryker Corporation | $203.74 | 2025 | N/A |
| Kuros Biosciences USA, INC | $187.76 | 2025 | Magnetos |
| Globus Medical, INC. | $103.17 | 2024-2025 | Altera, Excelsius Gps, Modulus |
| Kci USA, INC. | $54.59 | 2022 | |
| Irras USA, INC. | $45.54 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $44.25 | 2024 | Andexxa |
| Baxter Healthcare | $26.50 | 2025 | Floseal |
| Pfizer INC. | $23.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Ridenour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.